<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
66993-360-87
</NDCCode>
<PackageDescription>
450 mL in 1 BOTTLE, GLASS (66993-360-87)
</PackageDescription>
<NDC11Code>
66993-0360-87
</NDC11Code>
<ProductNDC>
66993-360
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Amphetamine Extended-release Oral Suspension
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Amphetamine
</NonProprietaryName>
<DosageFormName>
SUSPENSION, EXTENDED RELEASE
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20200930
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA AUTHORIZED GENERIC
</MarketingCategoryName>
<ApplicationNumber>
NDA204325
</ApplicationNumber>
<LabelerName>
Prasco Laboratories
</LabelerName>
<SubstanceName>
AMPHETAMINE
</SubstanceName>
<StrengthNumber>
1.25
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
</Pharm_Classes>
<DEASchedule>
CII
</DEASchedule>
<Status>
Deprecated
</Status>
<LastUpdate>
2021-11-16
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20211231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20200930
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>